Industry Gives US Trade Rep 12 Reasons Why Tariffs on Chinese Medtech Imports Are A Bad Idea
Executive Summary
The US Trade Representative office's decision in March to include devices, imaging machines and diagnostics on a list of Chinese imports destined for a 25% tariff has riled up the industry. A half-dozen medtech organizations protested the move in comments and testimony this week, supplying USTR with 12 reasons why the tariffs are a very bad idea.
You may also be interested in...
US Trade Rep Cuts 22 China-Made Devices From Tariffs List, But Retains 27
While the Trump administration appears to have been partially persuaded by industry arguments that a host of China-made medtech items do not belong on a list of items earmarked for a 25% tariff starting July 6, there are still 27 devices – or accessories – that remain.
Medtech Execs Stomping The Hill On Device Tax, Diagnostics Reforms
Several dozen top medtech executives are walking the halls of Congress today to meet with congressional leaders and staffers to lobby for a full repeal of the medical device excise tax and diagnostics regulatory reforms, among other issues.
AdvaMed To Plead With USTR To Spare Medtech In China Tariffs
In prepared remarks shared with Medtech Insight, AdvaMed plans to argue that tariffs imposed on medtech products made in China would disrupt an ongoing "action plan" the industry is pursuing to achieve reciprocal market access between the US and China for the industry.